TGen study predicted changing Lyme disease habitat across the West Coast
On Mar. 16, 2021, TGen announced a study that suggested ecosystems suitable for harboring ticks that carry debilitating…
-
-
NeuroRx initiated phase 2/3 study of inhaled ZYESAMI for severe COVID-19 with UCI Health
On Feb. 3, 2021, RELIEF THERAPEUTICS affirmed that its collaboration partner NeuroRx had initiated a phase 2/3 clinical…
-
Ajinomoto Bio-Pharma and Humanigen expanded agreement to support fill finish for COVID-19 therapeutic
On Jan. 27, 2021, Ajinomoto Bio-Pharma Services and Humanigen announced the companies will be expanding their manufacturing agreement…
-
The USDA confirmed COVID-19 in gorillas at San Diego Zoo Safari Park
On Jan. 13, 2021, the USDAﾒs (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 (the virus that…
-
First evidence of UK coronavirus variant in California confirmed by Scripps Research lab
On Jan. 4, 2021, a research partnership between scientists at Scripps Research and UC San Diego found the…
-
Biotechnology | CRISPR | FDA | Therapeutics
CIRM-funded project targeting sickle cell disease received green light for clinical trial
On Dec.14, 2020, the US Food and Drug Administration (FDA) announced they had granted Investigational New Drug (IND)…
-
LA County launched holiday COVID-19 home test collection pilot
On Dec. 4, 2020, Los Angeles County launched a new COVID-19 home test collection program, which allowed certain…
-
FDA approved first PSMA-targeted PET imaging drug for men with prostate cancer
On Dec. 1, 2020, the FDA approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) ﾖ the first drug for…
-
FDA expanded approval of influenza treatment to post-exposure prevention
On Nov. 23, 2020, the U.S. Food and Drug Administration (FDA) expanded the approved indication for Genentech’s Xofluza…
-
CIRM Board approved four new clinical trials
On Nov.12, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved four new clinical…
-
ImmunityBio, NantKwest announced positive interim phase 1 safety data of hAd5 COVID-19 vaccine dose study
On Nov. 10, 2020, ImmunityBio and NantKwest, a clinical-stage, natural killer cell-based therapeutics company, announced they had administered…
-
Single-cell study of Ebola highlighted virus’s lethal maneuvers
On Nov. 6, 2020, in a study published in Cell, the researchers identified antiviral defense genes that the…
-
Vacaville unveiled California Biomanufacturing Center and next generation of biotech development
On Oct. 22, 2020, the City of Vacaville announced the start of the next generation of development of…
-
Entos announced spin-off company Aegis Life to support global vaccine commercialization
On Oct. 15, 2020, Entos Pharmaceuticals announces that its San Diego-based spinout company Aegis Life, will pursuing U.S….
-
DOD awarded $481 million to Cue Health to increase domestic production capacity of point-of-care testing
On Oct. 13, 2020, the Department of Defense (DOD), on behalf of the U.S. Department of Health and…
-
Cue received $481 million award to expand domestic production capacity of molecular, point-of-care COVID-19 tests
On Oct. 13, 2020, Cue Health announced a $481 Million award from the Department of Defense (DOD), on…
-
Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ research
On Oct. 6, 2020, Hologic announced that two studies in the Journal of Clinical Microbiology demonstrated the utility…
-
FDA awarded contract to Stanford University to perform in-depth analysis of tissue samples to learn how SARS-CoV-2 causes COVID-19
On Oct. 5, 2020, the FDA awarded a research contract to the Stanford University School of Medicine to…
-
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Medicine | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency and the Chan Zuckerberg Initiative partnered to create COVID-19 database
On Sept. 8, 2020, a new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan…
-
U.S. Department of Defense sites selected for phase III COVID-19 vaccine trials
On Sept. 3, 2020, the U.S Department of Defense announced that five locations were identified to participate in…
-
Biotechnology | COVID-19 | FDA
OraSure’s ORAcollect-RNA device Included in EUA granted to MiraDx for SARS-CoV-2 test
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ﾷRNA (OR-100) collection device was included along with other…
-
Titers of antibodies against SARS-CoV2 did not decline within four months
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
-
Aegis Life launched to fight COVID-19 via DNA vaccines and therapeutics enabled by Fusogenix delivery technology
On Sept. 1, 2020, Entos Pharmaceuticals announce the launch of its San Diego-based spinout company Aegis Life, dedicated…
-
Genomic analysis revealed many animal species may be vulnerable to SARS-CoV-2 infection
On Aug. 24, 2020, humans are not the only species facing a potential threat from SARS-CoV-2, the novel…
-
FDA approved teatment for rare disease affecting optic nerves, spinal cord
On Aug. 17, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Enspryng (satralizumab-mwge) for the treatment…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approved oral treatment for spinal muscular atrophy
On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…
-
First clone of endangered Przewalski’s horse born in conservation effort to save the species
On Aug. 6, 2020, the world’s first successfully cloned endangered Przewalski’s horse was born. Revive & Restore, San…
-
Biotechnology | COVID-19 | NIH
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
-
StartX Med Alliance of Remote and Telehealth companies respond to shift in patient care during COVID-19 crisis
On Jul. 28, 2020, StartX, a non-profit startup community of more than 1600 Stanford faculty and alumni founders,…
-
CIRM board approved two new discovery research projects for COVID-19
On Jul. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new…
